Metronidazole resistance and virulence factors in Helicobacter pylori as markers for treatment failure in a paediatric population

被引:17
作者
López-Brea, M
Martínez, MJ
Domingo, D
Sánchez, I
Alarcón, T
机构
[1] Hosp Univ Princesa, Dept Clin Microbiol, Madrid, Spain
[2] Hosp del Nino Jesus, Gastroenterol Unit, Madrid, Spain
来源
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY | 1999年 / 24卷 / 02期
关键词
Helicobacter pylori; metronidazole; resistance; virulence factor; eradication; pediatric;
D O I
10.1016/S0928-8244(99)00024-3
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The eradication rate obtained using the classical triple therapy containing metronidazole, amoxicillin and bismuth citrate, was determined in 57. paediatric patients with digestive disorders, according to the susceptibility to metronidazole of the Helicobacter pylori strains (determined by agar dilution) and the cagA and vacA status (determined by PCR). Eradication was obtained in 38 out of 43 patients (85.3%) infected by H. pylori with metronidazole MIC less than or equal to 2 mg l(-1), in 3 out of 6 patients (50%) when MIC was 4-8 mg l(-1) and in 4 out of 8 patients (50%) when MIC was > 8 mg l(-1). Among patients infected with cagA+ and cagA - strains an eradication rate of 75% (6/8) and 75% (18/24) was found, and 50% (3/6) and 80% (21/26) among vacA s1- and vacA s2-infected subjects (P > 0.05). H. pylori eradication depends on the susceptibility of the strain to metronidazole, being higher in patients infected with susceptible H. pylori. However, according to our data the cagA or vacA status was not an important factor in treatment failure in the eradication of H. pylori. (C) 1999 Federation of European Microbiological Societies. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:183 / 188
页数:6
相关论文
共 29 条
  • [1] Primary and acquired Helicobacter pylori resistance to clarithromycin, metronidazole, and amoxicillin -: Influence on treatment outcome
    Adamek, RJ
    Suerbaum, S
    Pfaffenbach, B
    Opferkuch, W
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 1998, 93 (03) : 386 - 389
  • [2] Atherton J, 1997, CURR OPIN GASTROEN, V13, P20
  • [3] MOSAICISM IN VACUOLATING CYTOTOXIN ALLELES OF HELICOBACTER-PYLORI - ASSOCIATION OF SPECIFIC VACA TYPES WITH CYTOTOXIN PRODUCTION AND PEPTIC-ULCERATION
    ATHERTON, JC
    CAO, P
    PEEK, RM
    TUMMURU, MKR
    BLASER, MJ
    COVER, TL
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (30) : 17771 - 17777
  • [4] HIGH PREVALENCE OF HELICOBACTER-PYLORI METRONIDAZOLE RESISTANCE IN MIGRANTS TO EAST LONDON - RELATION WITH PREVIOUS NITROIMIDAZOLE EXPOSURE AND GASTRODUODENAL DISEASE
    BANATVALA, N
    DAVIES, GR
    ABDI, Y
    CLEMENTS, L
    RAMPTON, DS
    HARDIE, JM
    FELDMAN, RA
    [J]. GUT, 1994, 35 (11) : 1562 - 1566
  • [5] BELL GD, 1992, ALIMENT PHARM THERAP, V6, P427
  • [6] Broutet N, 1998, GUT, V43, pA79
  • [7] Prevalence of metronidazole resistant Helicobacter pylori strains among Chinese peptic ulcer disease patients and normal controls in Hong Kong
    Ching, CK
    Leung, KP
    Yung, RWH
    Lam, SK
    Wong, BCY
    Lai, KC
    Lai, CL
    [J]. GUT, 1996, 38 (05) : 675 - 678
  • [8] MOLECULAR CHARACTERIZATION OF THE 128-KDA IMMUNODOMINANT ANTIGEN OF HELICOBACTER-PYLORI-ASSOCIATED WITH CYTOTOXICITY AND DUODENAL-ULCER
    COVACCI, A
    CENSINI, S
    BUGNOLI, M
    PETRACCA, R
    BURRONI, D
    MACCHIA, G
    MASSONE, A
    PAPINI, E
    XIANG, ZY
    FIGURA, N
    RAPPUOLI, R
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (12) : 5791 - 5795
  • [9] METRONIDAZOLE SUSCEPTIBILITY TESTING FOR HELICOBACTER-PYLORI - COMPARISON OF DISK, BROTH, AND AGAR DILUTION METHODS AND THEIR CLINICAL RELEVANCE
    DECROSS, AJ
    MARSHALL, BJ
    MCCALLUM, RW
    HOFFMAN, SR
    BARRETT, LJ
    GUERRANT, RL
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1993, 31 (08) : 1971 - 1974
  • [10] Helicobacter pylori
    Dunn, BE
    Cohen, H
    Blaser, MJ
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 1997, 10 (04) : 720 - +